Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kempf

Showing results (411-420 of 415) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 415 results.
Parasites & Vectors|November 10, 2020
Parasites and vector-borne diseases disseminated by rehomed dogsIan Wright, Frans Jongejan, Mary Marcondes, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Parasites & Vectors|November 9, 2022
Vector-borne and other pathogens of potential relevance disseminated by relocated catsRicardo Guillermo Maggi, Vicky Halls, Friederike Krämer, et al.
ACS Omega|February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> GrowthPeter C Ray, Margaret Huggett, Penelope A Turner, et al.
ACS Infectious Diseases|October 6, 2016
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosisYumi Park, Angela Pacitto, Tracy Bayliss, et al.
Pageof 42

Showing results (411-420 of 415) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 415 results.
Parasites & Vectors|November 10, 2020
Parasites and vector-borne diseases disseminated by rehomed dogsIan Wright, Frans Jongejan, Mary Marcondes, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Parasites & Vectors|November 9, 2022
Vector-borne and other pathogens of potential relevance disseminated by relocated catsRicardo Guillermo Maggi, Vicky Halls, Friederike Krämer, et al.
ACS Omega|February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> GrowthPeter C Ray, Margaret Huggett, Penelope A Turner, et al.
ACS Infectious Diseases|October 6, 2016
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosisYumi Park, Angela Pacitto, Tracy Bayliss, et al.
Pageof 42